NYLI Candriam U.S. Mid Cap Equity ETF Rating $40.34 +0.31 (+0.77%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort Interest NYLI Candriam U.S. Mid Cap Equity ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IQSM Aggregate RatingModerate Buy 2.75Holdings in IQSM have an aggregate rating of Moderate Buy based on 413 analyst ratings issued in the past year covering 25 companies (19.1% of the portfolio).IQSM Aggregate Price Target$40.34High Prediction$40.34Average Prediction$40.34Low Prediction$40.34Holdings in IQSM have an aggregate price target of $40.34 and a range of $40.34 to $40.34 covering 25 companies (19.1% of the portfolio).IQSM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by NYLI Candriam U.S. Mid Cap Equity ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IQSM Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.36%RVMDRevolution Medicines$210.87+0.8%2.5196 of 5 stars2.95$200.74 -4.8%22Analyst ForecastInsider TradeAnalyst Revision0.97%NVTnVent Electric$151.88+2.5%4.8233 of 5 stars3.18$199.86 31.6%17Positive NewsAnalyst Downgrade0.96%TWLOTwilio$240.53+6.1%3.8863 of 5 stars3.00$249.68 3.8%270.95%USFDUS Foods$104.48-0.3%3.4993 of 5 stars2.73$113.92 9.0%15Positive News0.91%BURLBurlington Stores$258.00+0.4%4.4824 of 5 stars2.70$370.75 43.7%20Trending NewsEarnings ReportAnalyst Forecast0.89%OKTAOkta$170.42+4.5%3.2322 of 5 stars2.79$172.92 1.5%43Analyst ForecastAnalyst RevisionGap Up0.88%FFIVF5$392.15+0.3%3.6897 of 5 stars2.36$416.63 6.2%11Positive News0.79%GHGuardant Health$161.04-1.2%3.0988 of 5 stars2.96$183.78 14.1%25Positive NewsAnalyst ForecastGap Down0.74%MTSIMACOM Technology Solutions$259.95+0.9%4.6405 of 5 stars2.87$341.25 31.3%15Positive NewsAnalyst RevisionGap Down0.73%MKSIMKS$249.65-0.7%4.9824 of 5 stars2.81$382.86 53.4%16Positive News0.71%ROKURoku$158.31+0.4%2.4794 of 5 stars2.33$156.17 -1.4%27Trending NewsInsider Trade0.71%VTRSViatris$16.94-0.9%2.5863 of 5 stars2.57$17.50 3.3%70.70%SNXTD SYNNEX$261.64+3.4%4.8594 of 5 stars2.80$294.67 12.6%10Positive News0.68%MRNAModerna$148.87-1.3%1.476 of 5 stars2.08$76.72 -48.5%24Trending NewsAnalyst DowngradeInsider TradeOptions VolumeAnalyst RevisionGap Down0.67%ITTITT$203.71+1.3%4.7831 of 5 stars2.82$244.82 20.2%11Positive NewsInsider TradeAnalyst Revision0.66%CHRWC.H. Robinson Worldwide$146.68+1.0%4.9142 of 5 stars2.68$197.00 34.3%25Analyst Downgrade0.66%BALLBall$62.97-0.5%4.4314 of 5 stars2.54$71.69 13.9%13Trending NewsAnalyst Revision0.66%IEXIDEX$223.17-0.6%4.8753 of 5 stars2.80$260.80 16.9%10Positive News0.65%JLLJones Lang LaSalle$362.63+3.6%4.8912 of 5 stars2.86$433.60 19.6%7Positive News0.65%LSCCLattice Semiconductor$113.63-0.2%4.5244 of 5 stars3.07$147.46 29.8%14Positive News0.64%KIMKimco Realty$23.94-0.6%4.0255 of 5 stars2.53$26.56 10.9%17Positive News0.64%YUMCYum China$43.71-2.3%4.7643 of 5 stars2.75$59.21 35.5%4Positive NewsGap Down0.63%NLYAnnaly Capital Management$22.85+0.6%3.5982 of 5 stars2.75$24.33 6.5%12Positive NewsAnalyst Downgrade0.63%ZBRAZebra Technologies$357.50+1.8%3.9488 of 5 stars2.85$381.00 6.6%13Positive News0.61%NDSNNordson$317.49+0.3%4.2959 of 5 stars2.63$326.57 2.9%8Positive NewsDividend IncreaseAnalyst Upgrade This page (NYSEARCA:IQSM) was last updated on 9/3/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NYLI Candriam U.S. Mid Cap Equity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share NYLI Candriam U.S. Mid Cap Equity ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
